Tue, Mar 24 · 9:00

Developing a novel therapeutic candidate for autoimmune diseases is a complex challenge. Currently, traditional preclinical models do not provide the accuracy to understand the mechanisms of action and lack translational specificity for clinical approval. Over the last few years, we have seen breakthroughs in more advanced model utilization to validate novel target and biologic pathways, enabling faster preclinical-clinical drug development.

The PREDiCT: Autoimmune Disease Modeling Summit arrives in San Francisco, March 24-26 to showcase the latest therapeutic targets to deepen understanding of disease pathogenesis and improve drug development.

Join us as we bring together 60+ experts across the autoimmune industry to understand the unique drivers of disease symptomology.

Apply the latest case study evidence from novel therapeutic targets to increase your preclinical model validity and candidate success. With the latest case studies from Autoimmune Centers for Excellence, Immunic AG, Allergan, Cue Biopharma, the 3-day summit will provide you with validated mechanisms to improve your preclinical and clinical outcomes and accelerate your autoimmune pipeline.

URLs:

Website https://go.evvnt.com/563050-2?pid=5731

Brochure https://go.evvnt.com/563050-3?pid=5731

Prices:
Conference + Workshop (Pharma & Biotech): USD 2448.00
Conference Only (Pharma & Biotech): USD 2099.00
Workshop Only (Pharma & Biotech): USD 499.00
Conference + Workshop (Academic): USD 1998.00
Conference Only (Academic): USD 1699.00
Workshop Only (Academic): USD 399.00
Conference + Workshop (Vendor): USD 3398.00
Conference Only (Vendor): USD 2999.00

Speakers: Jason DeVoss, Principal Scientist, Amgen Inc., Hella Kohlhof, Chief Scientific Officer, Immunic AG, Changyun Hu, Senior Scientist, Jounce Therapeutics, Anish Suri, Chief Scientific Officer, Cue Biopharma, David Fox, Professor of Rheumatology and Professor of Internal Medicine, University of Michigan, Josef Buttigieg, Associate Professor, University of Regina, Marije Koenders, Assistant Professor, Radboud Institute for Molecular Life Sciences (RIMLS), Sunhwa Kim, Principal Scientist, Merck & Co, Jessica Kenison-White, Senior Scientist, AnTolRx Inc., Michael Mingueneau, Associate Director & Senior Scientist, Biogen Idec, Roland Grenningloh, Senior Director - Immunology Neurology, EMD Serono, Siddharth Sukumaran, Senior Scientist, Genentech, Alexis Scherl, Scientist, Research Pathology, Genetech, Zuoming Sun, Professor, City of Hope, Stephen Miller, Professor - Microbiology, Immunology & Dermatology, Cour Pharmaceutical Development Company, Peter Illyinskii, Senior Directo, Selecta Biosciences